SCHEMBL29317638

SCHEMBL29317638

CCOC(=O)[C@@H]1CCC(=C(F)F)[C@@H](NC(=O)OC(C)(C)C)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ BTK Q06187 1/20 0.37
▸ GAA P10253 2/20 0.36
▸ PDK1 Q15118 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ CTSL P07711 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ MAOB P27338 2/20 0.32
▸ MAOA P21397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30279188 0.84 ALDH1A1 (0.46) KMT2AALDH1A1TSHRMEN1BTK
SCHEMBL28803526 0.84 ALDH1A1 (0.46) KMT2AALDH1A1TSHRMEN1BTK
SCHEMBL11888286 0.83 KMT2A (0.48) KMT2AALDH1A1TSHRMEN1BTK
SCHEMBL22645710 0.78 ALDH1A1 (0.46) KMT2AALDH1A1TSHRMEN1BTK
SCHEMBL22645711 0.78 ALDH1A1 (0.46) KMT2AALDH1A1TSHRMEN1BTK
SCHEMBL23036707 0.78 ALDH1A1 (0.46) KMT2AALDH1A1TSHRMEN1BTK
SCHEMBL22661081 0.78 ALDH1A1 (0.46) KMT2AALDH1A1TSHRMEN1BTK
SCHEMBL31601434 0.78 ALDH1A1 (0.46) KMT2AALDH1A1TSHRMEN1BTK
SCHEMBL18733238 0.76 GAA (0.42) KMT2ABTKGAAL3MBTL1NFKB1
SCHEMBL23912326 0.76 BTK (0.55) KMT2AALDH1A1TSHRMEN1BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239738-A1 (S)-3-AMINO-4-(DIFLUOROMETHYLENE)CYCLOHEXENE AND CYCLOHEXANE CARBOXYLIC ACID AND USES THEREOF AS SELECTIVE INACTIVATORS OF HUMAN ORNITHINE AMINOTRANSFERASE (hOAT) NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-07-18 — — US disclosed
US-20240239738-A1 (S)-3-AMINO-4-(DIFLUOROMETHYLENE)CYCLOHEXENE AND CYCLOHEXANE CARBOXYLIC ACID AND USES THEREOF AS SELECTIVE INACTIVATORS OF HUMAN ORNITHINE AMINOTRANSFERASE (hOAT) NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239738-A1 (S)-3-AMINO-4-(DIFLUOROMETHYLENE)CYCLOHEXENE AND CYCLOHEXANE CARBOXYLIC ACID AND USES THEREOF AS SELECTIVE INACTIVATORS OF HUMAN ORNITHINE AMINOTRANSFERASE (hOAT) AADAT, DLAT, OAT KMT2A 625/4885ALDH1A1 115/4885TSHR 1658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback